Identification S100A9 as a potential biomarker in neuroblastoma

BACKGROUND: More than half of Neuroblastoma (NB) patients presented with distant metastases and the relapse of metastatic patients was up to 90%. It is urgent to explore a biomarker that could facilitate the prediction of metastasis in NB patients. METHODS AND RESULTS: In the present study, we syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xian, Xue, Yukun, Feng, Jiao, Tian, Qingwu, Zhang, Yunyuan, Wang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604885/
https://www.ncbi.nlm.nih.gov/pubmed/34689294
http://dx.doi.org/10.1007/s11033-021-06783-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604885/
https://www.ncbi.nlm.nih.gov/pubmed/34689294
http://dx.doi.org/10.1007/s11033-021-06783-2

Ejemplares similares